Acinetobacter species as nosocomial pathogens
Author:
Publisher
Springer Science and Business Media LLC
Subject
Infectious Diseases,Microbiology (medical),General Medicine
Link
http://link.springer.com/content/pdf/10.1007/BF01682159.pdf
Reference48 articles.
1. Humphreys H, Towner KJ, Crowe M, Webster C, Winter R:Acinetobacter infections, intensive care units, and handwashing. Lancet (1995) 345:121
2. Ehrenstein B, Bernards AT, Dijkshoorn L, Gerner-Smidt P, Towner KJ, Bouvet PJM, Daschner FD, Grundmann H:Acinetobacter species identification by using tRNA spacer fingerprinting. Journal of Clinical Microbiology (1996) 34:2414–2420
3. Bergogne-Bérézin E, Towner KJ:Acinetobacter spp. as nosocomial pathogens: microbiological, clinical, and epidemiological features. Clinical Microbiology Reviews (1996) 9:148–165
4. Seifert H, Baginsky R, Schulze A, Pulverer G: The distribution ofAcinetobacter species in clinical culture materials. Zentralblatt für Bakteriologie (1993) 279:544–552
5. Emory TG, Gaynes RP: An overview of nosocomial infections, including the role of the microbiology laboratory. Clinical Microbiology Reviews (1993) 6:428–442
Cited by 100 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Acinetobacter;Encyclopedia of Food Safety;2024
2. A systematic review and meta-analysis for risk factor profiles in patients with resistant Acinetobacter baumannii infection relative to control patients;International Journal of Risk & Safety in Medicine;2023-12-07
3. Evaluation of the Antimicrobial Resistance Pattern of Nosocomial Infections in Patients Hospitalized in Chamran Heart Educational, Medical, and Research Center of Isfahan;Journal of Research in Pharmacy Practice;2023-10
4. Emerging multidrug resistant Acinetobacter baumannii among patients in intensive care unit: an implication for extended global threat;International Journal of Surgery: Global Health;2023-09
5. Physiologically-based pharmacokinetic modeling to inform dosing regimens and routes of administration of rifampicin and colistin combination against Acinetobacter baumannii;European Journal of Pharmaceutical Sciences;2023-06
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3